drugset / Trial / NCT00436371
Amisulpride in Schizophrenic Acute Phase Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To collect the safety and response of using Amisulpride in acute schizophrenic patients
Timeline
- Start
- 2005-05
- Primary completion
- 2006-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | 400 mg | Oral |
| Subject | Amisulpride | Small molecule | 800 mg | Oral |